Literature DB >> 9177226

High level expression of p27(kip1) and cyclin D1 in some human breast cancer cells: inverse correlation between the expression of p27(kip1) and degree of malignancy in human breast and colorectal cancers.

S Fredersdorf1, J Burns, A M Milne, G Packham, L Fallis, C E Gillett, J A Royds, D Peston, P A Hall, A M Hanby, D M Barnes, S Shousha, M J O'Hare, X Lu.   

Abstract

The expression of cyclin-dependent kinase inhibitor p27(kip1) in human tumors and normal tissues was investigated using a panel of novel anti-p27(kip1) mAbs. An inverse correlation between expression of p27(kip1) and cell proliferation was generally observed after analyzing its expression in 25 different normal human tissues. In some highly proliferative human breast cancer cells, however, high level p27(kip1) expression was seen, indicating the existence of a mechanism by which some growing tumor cells may tolerate this inhibitor of cell cycle progression. Detailed studies demonstrated a correlation between the high level expression of p27(kip1) and cyclin D1 in human breast cancer cells. There was also an inverse correlation between the expression of p27(kip1) and the degree of tumor malignancy in human breast and colorectal cancers, indicating that p27(kip1) may be a useful prognostic marker in these cancers.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9177226      PMCID: PMC21058          DOI: 10.1073/pnas.94.12.6380

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  26 in total

1.  p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest.

Authors:  K Polyak; J Y Kato; M J Solomon; C J Sherr; J Massague; J M Roberts; A Koff
Journal:  Genes Dev       Date:  1994-01       Impact factor: 11.361

2.  Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals.

Authors:  K Polyak; M H Lee; H Erdjument-Bromage; A Koff; J M Roberts; P Tempst; J Massagué
Journal:  Cell       Date:  1994-07-15       Impact factor: 41.582

3.  Interleukin-2-mediated elimination of the p27Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin.

Authors:  J Nourse; E Firpo; W M Flanagan; S Coats; K Polyak; M H Lee; J Massague; G R Crabtree; J M Roberts
Journal:  Nature       Date:  1994-12-08       Impact factor: 49.962

4.  Inactivation of a Cdk2 inhibitor during interleukin 2-induced proliferation of human T lymphocytes.

Authors:  E J Firpo; A Koff; M J Solomon; J M Roberts
Journal:  Mol Cell Biol       Date:  1994-07       Impact factor: 4.272

5.  An immunomagnetic separation method using superparamagnetic (MACS) beads for large-scale purification of human mammary luminal and myoepithelial cells.

Authors:  C Clarke; J Titley; S Davies; M J O'Hare
Journal:  Epithelial Cell Biol       Date:  1994-01

6.  Cyclic AMP-induced G1 phase arrest mediated by an inhibitor (p27Kip1) of cyclin-dependent kinase 4 activation.

Authors:  J Y Kato; M Matsuoka; K Polyak; J Massagué; C J Sherr
Journal:  Cell       Date:  1994-11-04       Impact factor: 41.582

7.  Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining.

Authors:  C Gillett; V Fantl; R Smith; C Fisher; J Bartek; C Dickson; D Barnes; G Peters
Journal:  Cancer Res       Date:  1994-04-01       Impact factor: 12.701

Review 8.  Cdk inhibitors: on the threshold of checkpoints and development.

Authors:  S J Elledge; J W Harper
Journal:  Curr Opin Cell Biol       Date:  1994-12       Impact factor: 8.382

Review 9.  Mammalian G1 cyclins.

Authors:  G F Draetta
Journal:  Curr Opin Cell Biol       Date:  1994-12       Impact factor: 8.382

10.  Paradoxical accumulation of the cyclin-dependent kinase inhibitor p27kip1 during the cAMP-dependent mitogenic stimulation of thyroid epithelial cells.

Authors:  F Depoortere; J E Dumont; P P Roger
Journal:  J Cell Sci       Date:  1996-07       Impact factor: 5.285

View more
  75 in total

Review 1.  Cell cycle regulators: mechanisms and their role in aetiology, prognosis, and treatment of cancer.

Authors:  R J Michalides
Journal:  J Clin Pathol       Date:  1999-08       Impact factor: 3.411

Review 2.  Monoclonal antibodies.

Authors:  P N Nelson; G M Reynolds; E E Waldron; E Ward; K Giannopoulos; P G Murray
Journal:  Mol Pathol       Date:  2000-06

3.  p27 cell-cycle inhibitor is inversely correlated with lymph node metastases in right-sided colon cancer.

Authors:  D F Liu; K Ferguson; G S Cooper; W M Grady; J Willis
Journal:  J Clin Lab Anal       Date:  1999       Impact factor: 2.352

4.  Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27.

Authors:  J Vlach; S Hennecke; B Amati
Journal:  EMBO J       Date:  1997-09-01       Impact factor: 11.598

5.  Cooperative interactions of HER-2 and HPV-16 oncoproteins in the malignant transformation of human mammary epithelial cells.

Authors:  Kathleen M Woods Ignatoski; Michele L Dziubinski; Cheryl Ammerman; Stephen P Ethier
Journal:  Neoplasia       Date:  2005-08       Impact factor: 5.715

6.  Novel p27(kip1) C-terminal scatter domain mediates Rac-dependent cell migration independent of cell cycle arrest functions.

Authors:  Sandra S McAllister; Michelle Becker-Hapak; Giuseppe Pintucci; Michele Pagano; Steven F Dowdy
Journal:  Mol Cell Biol       Date:  2003-01       Impact factor: 4.272

Review 7.  p27 deregulation in breast cancer: prognostic significance and implications for therapy.

Authors:  A Alkarain; R Jordan; J Slingerland
Journal:  J Mammary Gland Biol Neoplasia       Date:  2004-01       Impact factor: 2.673

8.  Reinforcing targeted therapeutics with phenotypic stability factors.

Authors:  Paul Yaswen
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

9.  Expression of the cyclin-dependent kinase inhibitor p27 in transitional cell bladder cancers: is it a good predictor for tumor behavior?

Authors:  Latife Doganay; Semsi Altaner; Selcuk Bilgi; Esat Kaya; Galip Ekuklu; Kemal Kutlu
Journal:  Int Urol Nephrol       Date:  2003       Impact factor: 2.370

10.  p27kip1 deficiency impairs G2/M arrest in response to DNA damage, leading to an increase in genetic instability.

Authors:  Shannon R Payne; Shulin Zhang; Karen Tsuchiya; Russell Moser; Kay E Gurley; Gary Longton; Johan deBoer; Christopher J Kemp
Journal:  Mol Cell Biol       Date:  2007-10-22       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.